| 1 |
Donald J. Barnickel |
AT&T |
120 |
| 2 |
Jeffrey M. Cogen |
Dow Global Technologies |
9 |
| 3 |
Zhisheng Gao |
ExxonMobil |
4 |
| 3 |
Scott Beers |
Comcast |
4 |
| 3 |
Gregory Szewczyk |
Colgate-Palmolive |
4 |
| 3 |
David T. Ferrughelli |
ExxonMobil |
4 |
| #7 |
Julian Quintero |
Johnson & Johnson |
3 |
| #7 |
Gennadiy Itov |
L'Air Liquide, Societe Anonyme Pour L'Etude Et L'Exploitation Des Procedes Georges Claude |
3 |
| #7 |
Sean C. Ely |
Ingersoll-Rand |
3 |
| #7 |
Derek Wade Ohlarik |
Verizon |
3 |
| #7 |
Mark Hayzlett |
Lifecell |
3 |
| #7 |
Arkady RUBIN |
Arstat |
3 |
| #7 |
Michael P. Lanci |
ExxonMobil |
3 |
| #7 |
Lyndsay Schaeffer-Korbylo |
Colgate-Palmolive |
3 |
| #7 |
Nareshkumar Jain |
Johnson & Johnson |
3 |
| #7 |
Stephen T. Wrobleski |
Bristol-Myers Squibb |
3 |
| #7 |
Sara K. Green |
ExxonMobil |
3 |
| #18 |
Kenneth Smith |
Solidia Technologies |
2 |
| #18 |
Bill Calvin Robinson, Jr. |
Lumeta |
2 |
| #18 |
David C. Lindh, Sr. |
Johnson & Johnson |
2 |
| #18 |
Paul J. Tindall |
ExxonMobil |
2 |
| #18 |
Robert P. Lucchesi |
ExxonMobil |
2 |
| #18 |
Robert Woodbury |
Fidelity Information Services |
2 |
| #18 |
Anthony S. Mennito |
ExxonMobil |
2 |
| #18 |
Thomas James Vanden Boom |
Bristol-Myers Squibb |
2 |
| #18 |
Michael Berlin |
Arvinas Operations |
2 |
| #18 |
Rostam Jal Madon |
Basf Se |
2 |
| #18 |
Daniel P. Leta |
ExxonMobil |
2 |
| #18 |
John H. Dodd |
Ortho-Mcneil Pharmaceutical |
2 |
| #30 |
Kevin J. Klopfer |
Bristol-Myers Squibb |
1 |
| #30 |
Thomas D. Thompson |
Georgia Kaolin Company |
1 |
| #30 |
Machteld M. W. Mertens |
ExxonMobil |
1 |
| #30 |
Christopher W. Boyce |
Merck |
1 |
| #30 |
Matt Lyons |
— |
1 |
| #30 |
Dawn Elko |
Geo Specialty Chemicals |
1 |
| #30 |
Der-Yang Lee |
Mcneil-Ppc |
1 |
| #30 |
Paul Krzyzanowski |
Openpeak |
1 |
| #30 |
John S. Buchanan |
ExxonMobil |
1 |
| #30 |
Wivina LIJO |
L'Oreal |
1 |
| #30 |
Dave Narasimhan |
Ansell Healthcare Products |
1 |
| #30 |
Jeffrey Mastrull |
Colgate-Palmolive |
1 |
| #30 |
Jephté Augustin |
Johnson & Johnson |
1 |
| #30 |
John Giannouris |
Iqvia |
1 |
| #30 |
Aleksey I. Gerasyuto |
Morphic Therapeutic |
1 |
| #30 |
Martin Patrick Allen |
Bristol-Myers Squibb |
1 |
| #30 |
Matcheld Maria Wilfried Mertens |
ExxonMobil |
1 |
| #30 |
Robert V. DeLuca |
Ericsson |
1 |
| #30 |
Christopher G. Levins |
MIT |
1 |
| #30 |
David L. Kimball |
Johnson & Johnson |
1 |
| #30 |
Matthew Lombardo |
Merck |
1 |